Ashleigh Murphy-Beiner
Assistant Psychologist at Imperial College London Centre for Psychedelic Research
Data updated
Research Footprint
Ashleigh Murphy-Beiner appears in 10 tracked papers (2020–2024), most studied alongside Psilocybin, LSD and Ayahuasca, across Anxiety Disorders, Depressive Disorders and Major Depressive Disorder (MDD).
Most-cited paper: Trial of Psilocybin versus Escitalopram for Depression (1334 citations).
Frequent co-authors: Robin Murphy, David Nutt and Robin Carhart-Harris.
Background & Research
A. Murphy-Beiner is a clinical researcher active in contemporary psychedelic science whose published and in-preparation work centres on the psychological sequelae of psychedelic use and on strategies for coping and integration. Their research portfolio, drawn from mixed-methods, qualitative and survey-based studies, includes investigation of ayahuasca’s ‘afterglow’ and its associations with mindfulness and cognitive flexibility; a mixed-methods study and qualitative analyses documenting extended difficulties following psychedelic use; and interview work exploring ontological shock and existential distress after powerful psychedelic experiences.
Murphy-Beiner has also contributed to research comparing therapeutic outcomes of psilocybin-assisted therapy against conventional antidepressant treatment (psilocybin therapy v. escitalopram), with interest in personality change and broader mental-health outcomes. Across these projects they emphasise rigorous qualitative methodology, participant-centred descriptions of challenging experiences, and practical supports and coping strategies for people experiencing protracted difficulties after psychedelic sessions. (Note: the full given name was not available in the supplied sources.)
Key Impact
Recognised for empirical and qualitative work on the aftereffects of psychedelic experiences, emphasising extended difficulties, coping and integration as well as psychological outcomes after ceremonial and clinical use.
Collaboration Network
19 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Ashleigh Murphy-Beiner is associated with.
Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →Clerkenwell Health
UK psychedelic and CNS trial infrastructure provider with specialist trial sites, sponsor-facing psychiatric research support, recruitment pathways, and therapist-related trial expertise.
View stakeholder →